Skip to main content
CAREGEN CO.,LTD. logo

CAREGEN CO.,LTD. — Investor Relations & Filings

Ticker · 214370 ISIN · KR7214370009 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2026-05-27 Director's Dealing
Country KR South Korea
Listing KO 214370

About CAREGEN CO.,LTD.

http://caregen.co.kr

Caregen Co., Ltd. is a global biotechnology company specializing in the research, development, and commercialization of biomimetic peptides and growth factors. As a leader in peptide synthesis, the company leverages its world-class, patented technologies to create innovative products. Its portfolio provides comprehensive solutions for the anti-aging, aesthetic, and cosmeceutical sectors, with applications targeting skin pigmentation, inflammation, hair care, and weight management. The company's research focuses on developing peptide-based therapeutics and total health care solutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원·주요주주 특정증권등 소유상황보고서” filed by an executive (representative director) disclosing his personal shareholdings and changes (insider transaction). This matches our “Director's Dealing” category for insider trades by directors and executives.
2026-05-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 90% confidence The document is a 주식등의 대량보유상황보고서 (“Report on Large Shareholding Situation”) filed under Korea’s Capital Markets Act (Art.147). It details the reporter’s and related parties’ shareholdings, changes, purposes, and related contracts. This is a notification of changes in significant share ownership, matching the “Major Shareholding Notification” category (Code: MRQ).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 90% confidence The document is labeled "분기보고서" covering the period 2026-01-01 to 2026-03-31 (the first quarter of the 26th fiscal year), contains extensive financial statements, notes, management discussion, business overview, and auditor’s opinion. It is a comprehensive quarterly filing rather than a short earnings release or announcement. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-13 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 95% confidence The document is a Korean fair disclosure (“공정공시”) of provisional consolidated operating results for Q1 2026, listing key financial figures (sales, operating profit, net profit) versus previous periods and noting that these are preliminary. It is a brief earnings announcement of quarterly financial highlights rather than the full interim report. Therefore it fits the Earnings Release category. Q1 2026
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” filed to the Securities and Futures Commission and Korea Exchange. It details an executive’s shareholdings before and after trades, including changes in number of shares and ownership percentages. This corresponds to an insider transaction report by a director or major shareholder. Therefore, it is classified as Director’s Dealing (DIRS).
2026-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a "주식등의 대량보유상황보고서(일반)" filed under the Korean Capital Markets Act (Article 147) disclosing details of large shareholdings, changes in share counts and ratios, and related information by a major shareholder. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-04-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.